Johannes Frohlich

Title: The Innovative Contributions of Johannes Frohlich

Introduction

Johannes Frohlich is a notable inventor based in Dornbach im Wienerwald, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurological conditions. With a total of 4 patents to his name, Frohlich's work has the potential to impact the lives of many individuals suffering from various ailments.

Latest Patents

Frohlich's latest patents include groundbreaking research on derivatives and analogs of galanthamine, which are new compounds of general formula I. Additionally, he has developed benzazepine derivatives, which are drugs containing these compounds and their use in producing medications. These new derivatives of benzazepine, particularly those of benzofuro[3a,3,2,ef][2]benzazepin, are described in his patents. The drugs containing compounds of formulas (I) and/or (III) are designed for the treatment of Alzheimer's disease and related dementia conditions, as well as for the treatment of Langdon-Down syndrome.

Career Highlights

Throughout his career, Frohlich has worked with reputable companies in the pharmaceutical industry, including Sanochemia Ltd. and Sanochemia Pharmazeutica Aktiengesellschaft. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.

Collaborations

Frohlich has collaborated with esteemed colleagues such as Laszlo Czollner and Ulrich Jordis. These partnerships have fostered an environment of innovation and have led to the successful development of new pharmaceutical compounds.

Conclusion

Johannes Frohlich's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his dedication to improving healthcare. His work continues to pave the way for advancements in the treatment of neurological disorders.